Get the Stockscreener App
1.33
4.72%
0.06
Pre-market:
1.38
0.05
+3.76%
Neuronetics Inc stock is traded at $1.33, with a volume of 614.09K.
It is up +4.72% in the last 24 hours and down -14.19% over the past month.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.
See More
Previous Close:
$1.27
Open:
$1.27
24h Volume:
614.09K
Relative Volume:
0.36
Market Cap:
$91.09M
Revenue:
$69.23M
Net Income/Loss:
$-33.10M
P/E Ratio:
-1.1271
EPS:
-1.18
Net Cash Flow:
$-39.26M
1W Performance:
-0.75%
1M Performance:
-14.19%
6M Performance:
-59.82%
1Y Performance:
-73.72%
1-Day Range:
$1.27
$1.395
1-Week Range:
$1.17
$1.4252
52-Week Range:
$1.17
$5.92
Neuronetics Inc Stock (STIM) Company Profile
Name
Neuronetics Inc
Sector
Industry
Phone
877-600-7555
Address
3222 PHOENIXVILLE PIKE, MALVERN, PA
Compare STIM vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STIM
Neuronetics Inc
|
1.33 | 86.98M | 69.23M | -33.10M | -39.26M | -1.18 |
|
ABT
Abbott Laboratories
|
113.10 | 197.42B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
381.89 | 147.18B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
95.60 | 124.16B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
72.21 | 109.58B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
85.22 | 49.49B | 6.07B | 1.06B | 1.34B | 1.8063 |
Neuronetics Inc Stock (STIM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-13-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Oct-13-21 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-13-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jan-22-21 | Upgrade | William Blair | Mkt Perform → Outperform |
| Feb-06-20 | Initiated | BTIG Research | Buy |
| Jul-24-18 | Initiated | Canaccord Genuity | Buy |
View All
Neuronetics Inc Stock (STIM) Latest News
STIM (NASDAQ: STIM) insider notifies sales; Macan sold 20,?32 shares - Stock Titan
Neuronetics to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call - GlobeNewswire
Neuronetics Amends Registration Rights, Aligns With Major Shareholder - TipRanks
Neuronetics (STIM) revises Madryn registration rights and adds 2026 voting pact - Stock Titan
Aug Catalysts: Why is Neuronetics Inc stock going upDollar Strength & Real-Time Sentiment Analysis - baoquankhu1.vn
STIM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Neuronetics (NASDAQ:STIM) CEO Keith Sullivan Sells 8,452 Shares - MarketBeat
Macan, Neuronetics EVP, CLO and CS, sells $4.6k in STIM stock - Investing.com
Neuronetics (STIM) EVP sells 3,427 shares in tax withholding trade - Stock Titan
Neuronetics (STIM) CEO sells 8,452 shares to cover RSU tax - Stock Titan
STIM Technical Analysis & Stock Price Forecast - Intellectia AI
Keith Sullivan sells shares; STIM Form 144 lists 8,452 shares (STIM) - Stock Titan
STIM (NASDAQ: STIM) files Form 144 to sell 3,427 vested common shares - Stock Titan
STIM Stock Earnings: Neuronetics Beats EPS, Beats Revenue for Q1 2024 - TradingView
Neuronetics Grants 2025 Performance-Based Bonuses to Executives - TipRanks
Neuronetics board approves annual cash incentive awards for top executives - Investing.com Nigeria
Neuronetics board approves annual cash incentive awards for top executives By Investing.com - Investing.com Australia
Neuronetics (STIM) approves 2026 annual cash incentives for CEO and top executives - Stock Titan
Neuronetics (NASDAQ: STIM) grants 250,000 RSUs to its CFO - Stock Titan
Peering Into Neuronetics Inc's Recent Short Interest - Benzinga
Neuronetics (STIM) to Release Earnings on Tuesday - MarketBeat
Neuronetics CEO Sullivan sells $55,847 in shares By Investing.com - Investing.com Australia
Neuronetics, Inc. (NASDAQ:STIM) Short Interest Update - Defense World
Neuronetics CEO Sullivan sells $55,847 in shares - Investing.com UK
Neuronetics (NASDAQ:STIM) CEO Keith Sullivan Sells 33,847 Shares of Stock - MarketBeat
Malvern-Based Neuronetics Reports Preliminary 2025 Revenue Growth and Positive Cash Flow - MyChesCo
Neuronetics Revises Financial Results for Q4 and Full Year 2024 - MSN
Neuronetics (STIM) Reports Q3 Loss, Misses Revenue Estimates - MSN
What’s the RSI of Neuronetics Inc. stockShare Buyback & Real-Time Volume Surge Alerts - mfd.ru
Neuronetics (STIM) Is Down 9.0% After Turning Cash-Flow Positive On NeuroStar Demand Has The Bull Case Changed? - Sahm
Assessing Neuronetics (STIM) Valuation After Positive Cash Flow And Strong Preliminary Q4 Revenue - Yahoo Finance
How cyclical is Neuronetics Inc.’s revenue streamJuly 2025 Decliners & AI Driven Price Forecasts - mfd.ru
Can Neuronetics Inc. outperform in the next rallyMarket Activity Recap & Safe Entry Trade Signal Reports - mfd.ru
Keith Sullivan Sells 40,976 Shares of Neuronetics (NASDAQ:STIM) Stock - MarketBeat
STIM (NASDAQ: STIM) holder Keith Sullivan plans 33,847-share sale - Stock Titan
Neuronetics Beats Expectations with Strong Q4 Revenue and Cash Flow - timothysykes.com
Neuronetics Expects Q4 Revenue To Increase 86%; Stock Up - Nasdaq
Neuronetics reports 86% revenue growth in Q4 2025 By Investing.com - Investing.com Canada
Neuronetics (STIM) Stock Rises 41% After Hours: What's Going On? - Benzinga
STIM Closes 2025 with Strong Cash Position of $34.1 Million - GuruFocus
Neuronetics (STIM) Reports Positive Cash Flow Amid Strong Demand - GuruFocus
Neuronetics Reports Preliminary Fiscal Q4, 2025 Results - marketscreener.com
Neuronetics reports 86% revenue growth in Q4 2025 - Investing.com
Neuronetics Announces Selected Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results - The Manila Times
Neuronetics, Inc. Reports Strong Preliminary Financial Results for Fourth Quarter and Full Year 2025, Highlighting Significant Revenue Growth - Quiver Quantitative
Neuronetics lifts 2025 revenue 99%, books positive Q4 operating cash flow - Stock Titan
Market Review: Why is Neuronetics Inc stock going upMarket Performance Recap & Daily Risk Controlled Trade Plans - baoquankhu1.vn
Selling Neuronetics Shares at a Lower Price Than Current Market Value May Have Been a Costly Mistake for Insiders - 富途牛牛
Trade Report: Is Neuronetics Inc stock a buy or sellJuly 2025 Closing Moves & Technical Buy Zone Confirmations - baoquankhu1.vn
Sentiment Watch: Whats the profit margin of Neuronetics IncQuarterly Portfolio Report & Weekly Breakout Watchlists - baoquankhu1.vn
Aug Movers: Is Neuronetics Inc trading at a discount2025 Macro Impact & Real-Time Chart Breakout Alerts - baoquankhu1.vn
Neuronetics Inc Stock (STIM) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.27%
1.94%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):